Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Randal W. Scott,PhDCEO, InVitae Corporation*1,185,1173.64%2012-07-10
Steven Shak,M.D.EVP of R&D320,1160.98%2015-02-13
Joffre B. Baker,PhDChief Scientific Officer132,8460.41%2012-02-15
Dr. Fred E. Cohen,M.D.,D.Phil.N/A64,1280.2%2016-01-01
Kimberly J. PopovitsPresident and CEO35,6910.11%2016-01-12
G. Bradley ColeCOO27,428less than 0.1%2016-01-12
Mr. Dean L. SchornoCFO24,524less than 0.1%2014-06-10
Mr. James J. VaughnChief Commercial Officer24,076less than 0.1%2016-01-07
Brook H. ByersN/A23,951less than 0.1%2010-12-09
Kathy L. HibbsSVP & General Counsel15,787less than 0.1%2014-02-15

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.2-16.866,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.8-15.6827,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.3-20.5524,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117-8.6827,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.2-8.912,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.7-8.924,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.12.6530,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.352455.430,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.1-2.9430,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.241051.8330,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.2-2.9829,658 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-04-13Sell3,000203,001$31.2893.8-14.58Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.8-12.2229,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.7-16.26Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.4-16.0829,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.6-10.52Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.5-14.8221,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.9-16.326,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.4-20.14Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9999-19.01Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141-17.8421,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.7-23.26Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-24.4122,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.7-26.276,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.3-13.19Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.1-7.1322,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.5-10.4Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.4-11.222,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.2-2.34312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.22.49Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.80.49Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.2-1.2222,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$27189-1.04312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.1-0.04312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.32.38Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.5-3.2624,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.8-2.0922,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.60.68Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.46.523,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.81.79311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$2781-1.0422,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.5-5.78311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.3-3.7522,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.6-4.1615,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.7-2.41311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$2781-1.0424,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.6-15.2308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-10.93Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.5-5.1518,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57414-9.64308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-12.91Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.8-19.6421,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.9-23.486,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-22.73Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.1-19.921,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-14.8518,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.4-9.94308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-10.93Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.9-10.7818,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.7-20.78313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.8-22.12Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.3-17.8618,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-18.7821,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.5-15.156,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-18.98318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.6-19.1Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-19.421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-19.421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.2-20.6219,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.7-24.37318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.1-22.8Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.2-20.9717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.2-20.9717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.3-19.8313,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-20.29323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-25.11Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.5-25.5317,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.6-26.11
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.2-26.7313,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.5-27.21
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-26.596,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-27.57
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.9-27.65
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.5-28.717,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19186-28.15327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452604-26.69
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-25.436,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.2-22.19
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243-22.377,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-23Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.1-25.8217,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9990-25.7612,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-10.93Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.5-3.8512,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.4-6.4812,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.6-3.82
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.4-5.017,087 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481481-6.18
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.5-5.922,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.5-5.08
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.1-4.6714,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.5-7.136,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.5-4.5717,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.7-4.1614,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.7-3.68333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79139-3.85Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$2884-4.5717,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.7-4.026,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.1-0.41288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.3-0.6336,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.7-0.82338,768 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.5-2.2288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.2-1.91Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.1-3.92288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$2884-4.5717,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.6-6.6414,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-19.23Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.3-24.2343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.4-20.9217,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.2-20.911,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-23.2214,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-20.85348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.5-15.68Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.5-23.6814,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-24.092,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99175-23.64353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-23.04Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.2-12.3614,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-25.576,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-21.96358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-23.13Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-24.5Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.9-25.6714,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.3-19.64363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-19.9Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-19.9Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-20.33Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.9-21.3413,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-20.95367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.5-17.17
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.5-19.126,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.9-21.13
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-21.94Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.7-20.6917,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442-10.81
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-11.58Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.2-7.4513,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.7-6.08
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.4-5.286,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.7-4.33372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79139-3.85Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9828-4.518,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.8-6.54Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-11.7613,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-11.17377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.4-11.14Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.4-11.14Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-11.17377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.1-14.0319,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-13.95Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.9-10.7513,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.7-11.26
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.1-11.26
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.1-11.26
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-10.37
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.4-10.37
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934-10.37
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.2-8.05
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-8.05
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.7-8.05
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.5285-6.25Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.4-4.78
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.8-4.78
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.1-4.78
1,419,381 (Through Partnership)
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.7-5.05382,849 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.6-8.93
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.8-9.02
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.3-9.02
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.7-7.0920,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.8-7.0920,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.21.37
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.11.37
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.11.37
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.62.06Link
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.62.06Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.20.9414,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155-2.876,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.11.14Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.10.38Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.7-0.07382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$2828-4.5717,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.9-2.987,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.2-2.69Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.22.65387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.8-2.09Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.5-6.547,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.6-4.98
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.7-3.4
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.2-4.98
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.33.13
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.23.01
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.83.13
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.42.49392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711790-3.57
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.7-3.57
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.5-2.3
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.2-1.87
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.5-1.87
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.8-1.91Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.5-0.26
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.50.457,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.73.01
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.53.01
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.99.15
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.221.016,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.822.79392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.617.04Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.619.777,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.228.4Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.221.017,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.116.07392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.89.33Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.25.787,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.25.787,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.91.026,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.1-3.22392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.2-2.341,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.7-3.687,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.6-1.47392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.93.1318,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.84.011,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.12.02
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.92.02
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.71.98
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.52.067,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.6-2.27
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.1-2.3
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.3-2.3
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.84.58392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.50.9119,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.20.23Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.83.057,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.12.61Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.95.28Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.94.83Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.35.53Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.22.93Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.6-0.71Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.39.28Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.812.32Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.310Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.310Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.44.29Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.42.65Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.86.62Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.16.62Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.15.91Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.44.99Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.14.01Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.74.01Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.914.24Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.214.24Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.414.83Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.518.7Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.118.7Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244420.36Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.226.34Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.226.34Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.926.88Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.622.96Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.720.74Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.717.66Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.218.97Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.618.02Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514052.69Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.148.12Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.446.25Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.9527991.54Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.876.95Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.479.69Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.578.01Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.180.42Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.980.42Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.684.79Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.184.79Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.185.94Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.785.94Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.884.02Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.384.02Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.978.25Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.678.25Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.677.31Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.479.93Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.879.93Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.578.13Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.281.65Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.682.89Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.282.89Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.381.15Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2108.59Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.4104.75Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.1528388.83Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.056590.18Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.269.33Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.768.37Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.271.17Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.872.28Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.458.39Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.558.11Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.158.29Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538937.38Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338638.45Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.537.8Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.337.38Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.834.75Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.156.72Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.856.72Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.655.08Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.852.6Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.557.08Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.957.08Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.355.89Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.354.9Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.952.95Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.632.8Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.3910231.04Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.830.85Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.932.02Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.831.89Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.239.09Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.333.33Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.933.67Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.633.6Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.329.39Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.130.85Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.929.33Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179826.22Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.726.46Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.728.9Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.6724829.27Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.132.8Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.928.65Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.733.73Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.333.73Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.733.73Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.933.73Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.736.82Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010033.6Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.437.1Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.937.03Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.837.1Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.937.1Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.4223337.59Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.237.17Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.166.9
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.166.9
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.646.25
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.951.05
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199540.63
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.948.69
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.648.69
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.848.69
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.448.69
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.632.8
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.537.31
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.736.68
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.136.68
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.536.68
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.836.68
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.335.5
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.64.91
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.271175.74
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.837.73
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.639.68
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.624.16
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.429.71
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.429.71
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.228.15
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.837.66
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.17232.47
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.138.81
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.138.81
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.845.22
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.879234.47
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.879234.47
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.633.27
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.732.47
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.331.24
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.418.7
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.417.87
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.522.63
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.716.53
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.6910517.76
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.112.89
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460610.23
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.112.46
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125227.24
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.238.73
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20233.6
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.9223934.14
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.834.2
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.534.2
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.134.2
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.348.53
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522542.51
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.238.66
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.655.17
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.141.83
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.830.47
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.232.08
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.218.33
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.116.12
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.216.48
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.54.62
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.917.92
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.915.67
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.421.45
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.815.82
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.415.12
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.932.54
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.834.68
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.335.7
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.435.63
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.636.54
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.442.43
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.934.2
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.449037.45
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.226.16
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018840.56
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.939.46
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.352.16
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.963.73
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.963.73
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.163.73
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.163.73
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.861.06
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.761.06
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.961.06
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.661.06
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.972.39
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.672.39
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.5072.39
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.672.39
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.872.39
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.972.39
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.460.77
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.563.83
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.254.72
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.455.71
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.146.17
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.946.17
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.346.17
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.346.17
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.346.17
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.245.61
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.247.71
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.947.71
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.447.62
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.147.71
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.447.71
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.246.97
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.336.12
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.144.12
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.244.12
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.744.12
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.541544.12
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.54144.12
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.646.41
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.646.41
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.25174846.41
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.746.41
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.646.41
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.447.46
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.840.85
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.923.82
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.523.82
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.223.82
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.123.82
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.721.62
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.429.71
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.929.71
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.129.71
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.329.71
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.790.18Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.290.18Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.290.18Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.8122.67Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.2122.67Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column) and "Shares Owned Following This (Direct & Indirect)" transactions (sixth column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK